Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04661124 · ClinicalTrials.gov registry record
Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position
A clinical trial, sponsored by Heidelberg Engineering.
- Completed
- Registry status
- 88
- Enrollment target
NCT04661124: Completed study, sponsored by Heidelberg Engineering.
NCT04661124 is a clinical trial that has completed, run by Heidelberg Engineering. The registered enrollment target is 88 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04661124 has completed, sponsored by Heidelberg Engineering.
- COMPLETED
- Registry status
- 88 participants
- Enrollment target
Study Summary
This is a prospective clinical study conducted at one clinical site in the United States.
Primary Outcome
OCT, OCTA and IR cSLO - graded Good (2)/Average (1)/Poor (0)
Interventions
- DEVICE SPECTRALIS
- DEVICE SPECTRALIS with Flex Module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2020-12-10 |
| Est. Completion | 2024-04-22 |
What the finished NCT04661124 record still lists
NCT04661124 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 88 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which SPECTRALIS is the first listed.
NCT04661124 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04661124 about?
NCT04661124 is a clinical study titled "Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position". This is a prospective clinical study conducted at one clinical site in the United States.
What is the current status of trial NCT04661124?
This trial is currently completed. The enrollment target is 88 participants. The study started on 2020-12-10. Estimated completion is 2024-04-22.
What interventions are being tested in trial NCT04661124?
The interventions under investigation include: SPECTRALIS (DEVICE), SPECTRALIS with Flex Module (DEVICE).
Who is sponsoring clinical trial NCT04661124?
This trial is sponsored by Heidelberg Engineering, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03843463 · 88 participants · Phase 2
Escitalopram and Language Intervention for Subacute Aphasia
- NCT04066348 · 88 participants · Phase 2
TNF-α Treatment of Blast-Induced Tinnitus
- NCT04331704 · 88 participants · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
- NCT04536103 · 88 participants
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI